2025-02-19 - Analysis Report
## Merck & Co Inc (MRK) Stock Review

**0. Key Figures Overview:**

Merck & Co Inc (MRK) is a leading pharmaceutical company.  The following analysis is based on provided data.  Significant discrepancies exist between MRK's performance and the S&P 500 (VOO).

**1. Performance Comparison and Divergence:**

* **MRK Cumulative Return:** 36.60%
* **VOO (S&P 500) Cumulative Return:** 121.84%
* **Return Difference:** -85.2%  (MRK underperformed VOO significantly)
* **Relative Divergence:** 0.0 (Represents the lowest point in the historical range of divergence between MRK and VOO.)

The provided alpha and beta analysis show inconsistent performance relative to the market (VOO) across different time periods. While some periods show positive alpha (outperformance), others show significant negative alpha, highlighting the volatility and market dependence.  The high beta values suggest high sensitivity to market movements.


**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|-------|-------|
| 2015-2017  | -2.0% | 11.8% | -0.1 | 110.1 |
| 2016-2018  | 46.0% | 11.8% | 0.5 | 154.1 |
| 2017-2019  | 44.0% | 11.8% | 0.3 | 188.4 |
| 2018-2020  | 32.0% | 9.4% | 0.2 | 174.8 |
| 2019-2021  | 3.0% | 14.3% | 0.2 | 177.9 |
| 2020-2022  | 47.0% | 14.3% | 0.2 | 265.8 |
| 2021-2023  | 55.0% | 14.3% | 0.3 | 268.4 |
| 2022-2024  | 21.0% | 9.5% | 0.3 | 251.7 |
| 2023-2025  | -50.0% | 15.6% | 0.2 | 210.0 |


**2. Recent Price Movement:**

* **Closing Price:** $83.01
* **5-Day Moving Average:** $85.21
* **20-Day Moving Average:** $92.75
* **60-Day Moving Average:** $97.45

The stock price is trading below all three moving averages, indicating a bearish trend.

**3. Technical Indicators:**

* **RSI:** 12.95  (Extremely oversold; potential for bounce but also risk of further decline)
* **PPO:** -1.25 (Negative value suggests bearish momentum)
* **20-Day Relative Divergence Change:** -0.6 (Short-term downward trend)
* **Expected Return (vs. S&P 500):** 750.7% (This exceptionally high figure needs further clarification.  It's likely a projection under specific assumptions and may not be reliable.)

**4. Recent Earnings Analysis:**

| Date       | EPS     | Revenue          |
|------------|---------|-------------------|
| 2024-11-06 | $1.25   | $16.66 Billion   |
| 2024-08-05 | $2.15   | $16.11 Billion   |
| 2024-05-03 | $1.88   | $15.78 Billion   |
| 2023-11-03 | $1.87   | $15.96 Billion   |
| 2024-11-06 | $1.87   | $15.96 Billion   | *(Duplicate Entry, possible data error)*


There's a notable fluctuation in EPS.  Further analysis is needed to determine the underlying reasons for this variability.  Revenue figures show relatively stable but slightly decreasing trend. The duplicate entry on 2024-11-06 needs clarification.

**5. Financial Information:**

The absence of "Total Revenue" and "Gross Profit" data severely limits a comprehensive financial analysis. This missing information is crucial for evaluating the company's overall financial health and profitability.

**6. Overall Analysis:**

MRK significantly underperformed the S&P 500 over the analyzed period.  Technical indicators suggest an oversold condition, but the price is below key moving averages.  Earnings show some volatility.  The lack of crucial financial data hampers a complete assessment.  The exceptionally high projected expected return requires further investigation to understand its basis and validity.  Before investing, a thorough review of the missing financial data and a detailed understanding of the factors driving the projected return are necessary.  The high beta suggests substantial market risk.
